[1]
“To prophylax or not to prophylax? The role of trimethoprim/sulfamethoxazole as a prophylactic agent in systemic vasculitis: the case of antineutrophil cytoplasmic antibody-associated vasculitis and giant cell arteritis”, Reumatismo, vol. 77, no. 2, Feb. 2025, doi: 10.4081/reumatismo.2025.1791.